Fingerprint
Dive into the research topics of 'Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study
Vicky Cárdenas, Mathieu Le Gars, Carla Truyers, Javier Ruiz-Guiñazú, Frank Struyf, Alicia Colfer, Marc Bonten*, Alberto Borobia, Emil C Reisinger, Ingrid M C Kamerling, Macaya Douoguih, Jerald Sadoff
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
1
Downloads
(Pure)